Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Incorporating new research findings and ongoing debates surrounding the Aβ cascade hypothesis is crucial for improving early diagnosis and for guiding the development of effective treatments for AD.

Authors

Institutions

Publication Details

Journal
CNS Neuroscience & Therapeutics
Published
2025-12-01
DOI
https://doi.org/10.1002/cns.70688
Citations
1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Shiler Khaledi, Kamilia Ahmadi, Shamseddin Ahmadi, Kambiz Hassanzadeh
1 citations
CNS Neuroscience & Therapeutics
Alzheimer's disease research and treatments
1.16
article

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Shiler Khaledi, Kamilia Ahmadi, Shamseddin Ahmadi, Kambiz Hassanzadeh
article en
1 citations

Abstract

Incorporating new research findings and ongoing debates surrounding the Aβ cascade hypothesis is crucial for improving early diagnosis and for guiding the development of effective treatments for AD.

CNS Neuroscience & TherapeuticsVol. 31(12)
Tabriz University of Medical Sciences (IR), University of Kurdistan (IR), Environmental and Occupational Health Sciences Institute (US)
Openalex Percentile: Top 16%
Alzheimer's disease research and treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.